Piramal Pharma posts ₹5cr profit, revenue up 28% to ₹2,617.06cr

Business Oct 28, 2026

Piramal Pharma just turned things around with a ₹5 crore profit for July-September 2026, bouncing back from a hefty ₹99.22 crore loss last year.

Revenue shot up 28% to ₹2,617.06 crore, showing the company's business is picking up steam.

Piramal Pharma expenses ₹2,589.10cr shares up

Even with expenses climbing to ₹2,589.10 crore, the strong revenue growth helped balance things out.

Investors seemed happy with the results: Piramal Pharma's stock closed up 1.69% at ₹198.45 after the earnings news.